{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.27","value":"0.07803"},{"groupId":"OG001","spread":"15.50","value":"0.07379"},{"groupId":"OG002","spread":"16.76","value":"0.07573"},{"groupId":"OG003","spread":"12.37","value":"0.07386"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"title":"Cycle 1 Day 1: MPAUC0-6"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.91","value":"0.08204"},{"groupId":"OG001","spread":"17.19","value":"0.07722"},{"groupId":"OG002","spread":"17.48","value":"0.07960"},{"groupId":"OG003","spread":"14.05","value":"0.07742"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"title":"Cycle 1 Day 1: MPAUC0-12"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.94","value":"0.08209"},{"groupId":"OG001","spread":"18.93","value":"0.07516"},{"groupId":"OG002","spread":"19.59","value":"0.07855"},{"groupId":"OG003","spread":"7.881","value":"0.07942"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"3"}],"units":"Participants"}],"title":"Cycle 1 Day 1: MPAUC0-24"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"29.62","value":"0.06036"},{"groupId":"OG001","spread":"26.61","value":"0.06123"},{"groupId":"OG002","spread":"27.69","value":"0.06078"},{"groupId":"OG003","spread":"20.71","value":"0.06934"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"title":"Cycle 2 Day 1: MPAUC0-6"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"29.74","value":"0.06413"},{"groupId":"OG001","spread":"26.09","value":"0.06429"},{"groupId":"OG002","spread":"27.42","value":"0.06421"},{"groupId":"OG003","spread":"19.13","value":"0.07339"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"title":"Cycle 2 Day 1: MPAUC0-12"}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"description":"To further evaluate the PK of the granule formulation.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Global Cohort 1 (\\>=4 to \\<7 years)","id":"OG000","title":"Global Cohort 1"},{"description":"Global Cohort 2 (\\>=1 to \\<4 years)","id":"OG001","title":"Global Cohort 2"},{"description":"Global Cohorts (\\>=1 to \\<7 years)","id":"OG002","title":"Total in Global"},{"description":"Japan Cohort (\\>=1 to \\<7 years)","id":"OG003","title":"Japan Cohort"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Pharmacokinetic analysis set was used for analysis. Some records were excluded for given visits and analytes due to missing concentration data, issues taking the medication and usage of prohibited medications.","reportingStatus":"POSTED","timeFrame":"Pre-dose and 1, 2, 3, 4, 6, 8, 10-12 and 18-24 hours after selumetinib single dose on Cycle 1 Day 1. Pre-dose, 1, 2, 3, 4, 6, 8, and 10-12 hours post-dose on Cycle 2 Day 1 (each cycle is 28 days)","title":"Parent-to-metabolite Ratio for AUC0-6, AUC0-12 and AUC0-24 After Single and Multiple Dose Administration.","type":"SECONDARY","unitOfMeasure":"Ratio"}